Home Cart 0 Sign in  

[ CAS No. 2295-58-1 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 2295-58-1
Chemical Structure| 2295-58-1
Structure of 2295-58-1 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 2295-58-1 ]

Related Doc. of [ 2295-58-1 ]

Alternatived Products of [ 2295-58-1 ]

Product Details of [ 2295-58-1 ]

CAS No. :2295-58-1 MDL No. :MFCD00016456
Formula : C9H10O4 Boiling Point : -
Linear Structure Formula :- InChI Key :PTHLEKANMPKYDB-UHFFFAOYSA-N
M.W : 182.17 Pubchem ID :3362
Synonyms :
Chemical Name :1-(2,4,6-Trihydroxyphenyl)propan-1-one

Calculated chemistry of [ 2295-58-1 ]

Physicochemical Properties

Num. heavy atoms : 13
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.22
Num. rotatable bonds : 2
Num. H-bond acceptors : 4.0
Num. H-bond donors : 3.0
Molar Refractivity : 47.51
TPSA : 77.76 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : Yes
Log Kp (skin permeation) : -6.3 cm/s

Lipophilicity

Log Po/w (iLOGP) : 0.73
Log Po/w (XLOGP3) : 1.56
Log Po/w (WLOGP) : 1.4
Log Po/w (MLOGP) : 0.24
Log Po/w (SILICOS-IT) : 1.06
Consensus Log Po/w : 1.0

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.16
Solubility : 1.26 mg/ml ; 0.00689 mol/l
Class : Soluble
Log S (Ali) : -2.8
Solubility : 0.287 mg/ml ; 0.00157 mol/l
Class : Soluble
Log S (SILICOS-IT) : -1.41
Solubility : 7.04 mg/ml ; 0.0386 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.3

Safety of [ 2295-58-1 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P305+P351+P338 UN#:N/A
Hazard Statements:H315-H319 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 2295-58-1 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 2295-58-1 ]
  • Downstream synthetic route of [ 2295-58-1 ]

[ 2295-58-1 ] Synthesis Path-Upstream   1~6

  • 1
  • [ 108-73-6 ]
  • [ 79-03-8 ]
  • [ 2295-58-1 ]
YieldReaction ConditionsOperation in experiment
75%
Stage #1: With aluminum (III) chloride In carbon disulfide; nitrobenzene at 55℃; for 1 h;
Stage #2: at 55℃; for 1 h;
General procedure: AlCl3 (4 equiv) was added to a stirred phloroglucinol suspension (1 equiv) in CS2. Nitrobenzene was added to the solution over 30min. The solution was refluxed at 55°C for 30min. Acyl chloride (1equiv) dissolved in nitrobenzene was added to the reaction mixture over 30min before heating for another 30min. The reaction mixture was allowed to cool with stirring and then poured into an ice-water bath. Afterwards, 3M HCl was added. The organic solvents were removed under a reduced pressure, and the oily residue containing the acylphloroglucinol was extracted with Et2O. After removing the Et2O, the crude product was purified via flash chromatography (PE (bp. 50−70°C)/EtOAc 5:1→3:1) [21].
60%
Stage #1: With aluminum (III) chloride In carbon disulfide; nitrobenzene at 55℃; for 0.5 h;
Stage #2: for 0.5 h; Heating
General procedure: Phloroglucinol (3; 10.81 g, 85.8 mmol) in carbon disulphide (50 mL) was transferred into a two-necked round-bottomed flask and allowed to stir while aluminium trichloride (46.43 g, 351.8 mmol, 4.1 equiv) was added. Nitrobenzene (40 mL) was then added to the solution over 30 min. The solution was then heated under reflux at 55 °C for 30 min. A solution of 2-methylbutanoyl chloride (2) (10.89 g, 85.8 mmol) dissolved in 5 mL nitrobenzene was added to the reaction mixture over 30 min, followed by heating for another 30 min. The reaction mixture was allowed to cool with stirring and then poured into an ice-water bath (400 mL). 100 mL of 3 m hydrochloric acid was then added and the mixture extracted with diethyl ether (3 * 500 mL).
The organic solvents were removed under reduced pressure. The oily residue containing the acylphloroglucinol was subjected to VLC over SiGel PF254 using hexane and EtOAc of increasing polarity. The VLC fraction eluted with 30-45percent EtOAc in hexane gave (S)-2-methyl-1-(2,4,6-trihydroxyphenyl)butan-1-one as a pale yellow oil (9.71 g, 46.19 mmol, 54percent).
2.81%
Stage #1: With aluminum (III) chloride In dichloromethane at 33 - 40℃; for 0.166667 h;
Stage #2: for 0.25 h; Reflux
General procedure: The mixture of phloroglucinol (0.05 mol) and anhydrous aluminum chloride (0.1 mol) were dissolved in dichloromethane (50 mL). Phloroglucinol and aluminum chloride easily dissolved in the solvent and HCl was observed to be produced when the reaction temperature rose to about 33 °C. The mixture was heated for 10 min at 40 °C and the acyl chloride (0.05 mol) was added dropwise. After refluxing for 15 min, 0.05 mol of HCl was added to quench the reaction. The solvent was evaporated off, and the resultant product extracted with ethyl acetate. The ethyl acetate extract was purified using flash column chromatography over silica gel, eluted with petroleum ether/ethyl acetate (10:1) [22].
Reference: [1] Agricultural and Biological Chemistry, 1985, vol. 49, # 3, p. 719 - 724
[2] European Journal of Medicinal Chemistry, 2014, vol. 85, p. 621 - 628
[3] Australian Journal of Chemistry, 2005, vol. 58, # 7, p. 551 - 555
[4] European Journal of Medicinal Chemistry, 2018, vol. 155, p. 255 - 262
[5] Bioorganic and Medicinal Chemistry, 2006, vol. 14, # 13, p. 4402 - 4409
[6] Phytochemistry Letters, 2012, vol. 5, # 1, p. 144 - 149
[7] Molecules, 2014, vol. 19, # 8, p. 11645 - 11659
[8] Bioscience, Biotechnology, and Biochemistry, 1992, vol. 56, # 12, p. 2062 - 2063
[9] Australian Journal of Chemistry, 2008, vol. 61, # 9, p. 718 - 724
[10] European Journal of Medicinal Chemistry, 2017, vol. 125, p. 492 - 499
[11] Molecules, 2018, vol. 23, # 10,
[12] MedChemComm, 2018, vol. 9, # 10, p. 1698 - 1707
  • 2
  • [ 108-73-6 ]
  • [ 2295-58-1 ]
Reference: [1] Organic Letters, 2004, vol. 6, # 25, p. 4647 - 4650
[2] Patent: EP2660240, 2013, A1,
[3] Patent: US2013/303544, 2013, A1,
  • 3
  • [ 108-73-6 ]
  • [ 107-12-0 ]
  • [ 2295-58-1 ]
Reference: [1] Journal of the Chemical Society, 1931, p. 1255,1264
[2] Journal of the American Chemical Society, 1932, vol. 54, p. 2452
[3] Journal of the South African Chemical Institute, 1943, vol. 26, p. 41,45
[4] Yakugaku Zasshi, 1949, vol. 69, p. 431[5] Chem.Abstr., 1950, p. 3457
[6] Phytochemistry (Elsevier), 1983, vol. 22, # 1, p. 243 - 246
  • 4
  • [ 17397-82-9 ]
  • [ 2295-58-1 ]
Reference: [1] Tetrahedron, 1969, vol. 25, p. 707 - 714
  • 5
  • [ 108-73-6 ]
  • [ 123-62-6 ]
  • [ 2295-58-1 ]
Reference: [1] Journal of the South African Chemical Institute, 1943, vol. 26, p. 41,45
[2] Journal of Heterocyclic Chemistry, 2002, vol. 39, # 6, p. 1251 - 1258
  • 6
  • [ 108-73-6 ]
  • [ 802294-64-0 ]
  • [ 3145-11-7 ]
  • [ 2295-58-1 ]
Reference: [1] Bioscience, biotechnology, and biochemistry, 1992, vol. 56, # 11, p. 1769 - 1772
Same Skeleton Products
Historical Records